12 Best Global Stocks to Buy According to Hedge Funds
The United States has long been a magnet for global businesses seeking to tap into its robust economy and dynamic financial markets.
Novo Nordisk A S (NVO)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | GQG Partners Rajiv Jain | 12,994,533 | $1,117,789,791 | +75% | 1.65% |
| 2. | Fisher Asset Management Ken Fisher | 12,640,489 | $1,087,334,944 | -5% | 0.43% |
| 3. | Renaissance Technologies Jim Simons | 8,312,996 | $715,083,916 | +2% | 1.05% |
| 4. | 2,471,500 | $212,598,430 | +115% | 0.03% | |
| 5. | 2,283,200 | $196,400,864 | +71% | 0.03% |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 19,944,809 | $1,715,652,476 | 1.04% | |
| 2. | 15,492,384 | $1,332,654,883 | 0.11% | |
| 3. | 12,204,292 | $1,049,813,496 | 0.07% | |
| 4. | 11,384,481 | $979,293,095 | 2.38% | |
| 5. | 10,021,884 | $862,082,481 | 0.05% |
News See All
12 Most Oversold Healthcare Stocks to Buy Now
Healthcare costs and spending have been rising in the US. The Centers for Medicare & Medicaid Services reported that healthcare spending in the US reached $4.9 trillion in 2023, up 7.5% from 2022.
10 Best Drug Stocks to Buy Now
Large American pharmaceutical companies are showing a distinct trend never seen before: they are increasingly looking for medicines in China.
13 Best Foreign Dividend Stocks To Buy According to Analysts
Dividends have historically been a key driver of investor returns, contributing 85% of the broader market's total return since 1960.
Novo Nordisk A/S (NVO): A Bull Case Theory
We came across a bullish thesis on Novo Nordisk A/S (NVO) on Substack by Long-Term Pick. In this article, we will summarize the bulls’ thesis on NVO.
12 Best International Dividend Stocks To Buy Now
Dividend stocks have been grabbing investors' attention for a while now.
Billionaire Ken Fisher's Top 10 High Growth Stock Picks
Ken Fisher is the founder and executive chairman of Fisher Asset Management, a renowned investment and financial analysis expert.
Why Novo Nordisk (NVO) Is Climbing Today
Danish weight-loss drug maker Novo Nordisk (NVO) is jumping 5% after the company reported higher-than-expected net income for the fourth quarter.
Jim Cramer's Game Plan: 15 Stocks in Focus
Jim Cramer, the host of Mad Money, discussed the upcoming market and corporate activity to look forward to this week, which will be dominated by earnings reports from various companies and an important...
Novo Nordisk A/S (NVO): A Bull Case Theory
We came across a bullish thesis on Novo Nordisk A/S (NVO) on Long-Term Pick’s Substack by Dan. In this article, we will summarize the bulls’ thesis on NVO.
Billionaire Hedge Funds
